Unveiling an unrivaled breakthrough, Cyclic PSAP Peptide emerges as an exceedingly powerful therapeutic asset in the realm of Alzheimer's disease treatment. Its ingenious mechanism primarily revolves around honing in on the perplexing accumulation of beta-amyloid plaques within the enigmatic confines of the brain, an emblematic characteristic emblematic of this pernicious ailment. With unparalleled efficacy, this groundbreaking peptide systematically curtails the onerous burden of these plaques, ushering in a transformative era of enhanced cognitive functionality, potentially impeding the relentless progression of Alzheimer's.
CAT No: GR2175
CAS No:1443985-29-2
Chemical Name:(2S)-6-amino-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]hexanoic acid
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More